Aquestive Therapeutics, Inc.·4

Mar 9, 3:07 PM ET

Schobel Alexander Mark 4

4 · Aquestive Therapeutics, Inc. · Filed Mar 9, 2023

Insider Transaction Report

Form 4
Period: 2023-03-09
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
  • Award

    Common Stock

    2023-03-09+100,000982,871 total
Footnotes (1)
  • [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Documents

1 file
  • 4
    marketforms-59529.xmlPrimary

    PRIMARY DOCUMENT